Stay updated with latest developments in Mental Health, Psychiatry and Life in general.
COVID-19 has likely tripled depression rate, study finds
A first-of-its-kind study from the Boston University School of Public Health (BUSPH) finds 27.8% of U.S. adults had depression symptoms as of mid-April, compared to 8.5% before the COVID-19 pandemic.
Published in the journal JAMA Network Open, the study also found that income and savings are the most dramatic predictors of depression symptoms in the time of COVID.
Know more about the study here.
Seven firms in India get license for producing Covid-19 vaccine
The Central Drugs Standard Control Organisation has granted test license permission for manufacturing Covid-19 vaccine to seven firms.
These firms are:
- Aurobindo Pharma Limited, Hyderabad
- Bharat Biotech International Ltd, Hyderabad
- Biological E Ltd, Hyderabad
- Cadila Healthcare Ltd, Ahmedabad
- Gennova Biopharmaceuticals Limited, Pune
- Serum Institute of India, Pune
- Reliance Life Sciences, Mumbai
While a COVID-19 vaccine is likely to become available by early next year, it would take time to reach everyone.
Let’s keep the hopes thriving!
WHO steps up to make quality mental health services available more easily
In the world, close to 1 billion people are living with a mental disorder, 3 million people die every year from the harmful use of alcohol and one person dies every 40 seconds by suicide. The state of affairs have worsened due to the COVID-19 pandemic. Yet, few people around the world have access to quality mental health services.
That’s why, WHO with United for Global Mental Health and the World Federation for Mental Health, is calling for a massive scale-up in investment in mental health.
Know more about the initiative here.
Fixed bed charges for COVID patients, rules Bengal Government
As the number of COVID-19 patients keep on rising, hospitals are increasing their bed charges based on their fancies. This situation is creating additional pressure on the already disturbed population.
To put an end to this menace, the West Bengal Clinical Establishment Regulatory Commission on August 22 issued an advisory, clearly mentioning that hospitals need to keep bed charges the same as they were on March 1.
The move will bring huge relief to the patients.
To know more click here.
New blood test could aid in diagnosis of Alzheimer’s disease
According to a study published in the Journal of the American Medical Association (JAMA), a new blood test has the potential to differentiate between persons with and without Alzheimer’s disease and in persons who are at known genetic risk. This blood test can help in detecting the disease as early as 20 years before the onset of cognitive impairment. The study has also been presented at the Alzheimer’s Association International Conference.
To know more click here.